Visit COVID-19 resources

[Skip to Content]

Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening – Membership Consultation

12 July 2017

The Royal College of Ophthalmologists have, through a guideline development group (GDG) chaired by Professor Andrew Lotery, produced a new clinical guideline titled Hydroxychloroquine and Chloroquine Retinopathy: Recommendations on Screening.

A draft version of this guideline and the associated patient information leaflet has now been released for consultation and the College would welcome any comments or observations on the content, format or recommendations.

This is an opportunity for the membership of the College to contribute to and influence the form of the final guideline.

The purpose of this consultation is to obtain suggestions of additional sources of evidence which the GDG may wish to consider, or alternative interpretation of the evidence leading to a rephrasing or amendment of the recommendations.

We would be grateful if you could provide your comments by 31 July 2017.

If you have any questions relating to the guideline development process or wish to comment upon any aspect of this draft, please email Barny Foot (